6533b838fe1ef96bd12a3ac7

RESEARCH PRODUCT

High fat diets for weight loss among subjects with elevated fasting glucose levels: The PREDIMED study

ÁNgel M. Alonso-gómezMontserrat FitóMiguel ÁNgel Martínez-gonzálezMiguel ÁNgel Martínez-gonzálezDolores CorellaRamon EstruchJ. Alfredo MartínezArne AstrupJulio Martínez-gonzálezDora RomagueraXavier PintóMiguel Ruiz-canelaJordi Salas-salvadóJosé LapetraMads F. HjorthLuis Serra-majem

subject

0301 basic medicineComplete data030109 nutrition & dieteticsendocrine system diseasesMediterranean dietbusiness.industryEndocrinology Diabetes and MetabolismWeight changePublic Health Environmental and Occupational Healthnutritional and metabolic diseases030209 endocrinology & metabolismHigh fat dietCarbohydratePredimedFasting glucose03 medical and health sciences0302 clinical medicineAnimal scienceWeight lossInternal Medicinemedicinemedicine.symptombusiness

description

Abstract Aim We studied fasting plasma glucose (FPG) as a determinant of weight change on high-fat diets in the PREDIMED trial. Methods A total of 3,622 participants were randomized to receive one of two Mediterranean diets (n = 2,616) or a control diet (n = 1,006) for 5 years and had complete data for baseline FPG and body-weight development. Weight change by pre-treatment FPG categories ( Results The two Mediterranean diets contained 41.5 E% fat, 16.5 E% protein, and 40 E% carbohydrate whereas the control diet contained 37.8 E% fat, 16.8 E% protein and 43.2 E% carbohydrate. In the Mediterranean diet groups, participants with FPG≥115 lost 1.04 kg (95% CI 0.68; 1.41, n = 1115) whereas participants with FPG Conclusions Participants with elevated pre-treatment FPG lost more weight than participants with lower FPG on these three moderate to high fat diets. Although the effect size is small, results are important as these individuals represent those in most need of weight loss.

https://doi.org/10.1016/j.obmed.2020.100210